The FDA approval of denileukin diftitox (Lymphir) marked a significant shift in this paradigm. As a first-in-class immunotoxin, it employs a dual-action mechanism: directly targeting interleukin-2 (IL ...

The less directly you prepare for business, the better equipped you may be — because empathy, synthesis, and ethical ...

A new study published in the Journal of Autism and Developmental Disorders suggests that the ability to comprehend complex ...

Halogen bonds were first proposed as an activating interaction in 2008, but this alternative type of organocatalysis was ...

A breakthrough experiment, published in the Proceedings of the National Academy of Sciences, offers compelling support for ...

From structure confirmation to methodology improvements, making complex natural products has driven innovation in organic ...